March 19, 2025 - 22:32

Lument Finance Trust has announced its impressive annual earnings of $17.9 million, translating to a distributable income of $0.44 per share. This strong financial performance reflects the company's strategic initiatives and effective management in navigating the competitive landscape of the finance sector.
In a significant leadership move, the company has appointed Greg Calvert as its new President. Calvert’s extensive experience in finance and his proven track record in driving growth are expected to bolster the company’s operations and strategic direction as it continues to expand its portfolio.
Despite the challenges faced by the market, Lument Finance Trust has maintained a steady dividend payout, demonstrating its commitment to providing value to its shareholders. The combination of robust earnings and leadership transition positions the company well for future growth and reinforces its standing in the finance industry. Stakeholders are optimistic about the potential for further advancements under Calvert’s leadership.
September 12, 2026 - 00:50
US Tariff Refunds Slow as Government Collects More Than It Pays OutThe flow of tariff refunds from the US government has slowed sharply, with new figures showing the Treasury took in more money from tariffs than it returned to importers for the first time in...
September 11, 2026 - 02:46
Rayonier Advanced Materials’ (RYAM) Pricing Power Is Surging, But Volumes Tell Another StoryRayonier Advanced Materials reported second-quarter results on August 4 for the period ending June 27, showing a mixed picture of financial performance. Net sales reached $376 million, an 18...
September 10, 2026 - 21:54
OpenAI Rolls Out ChatGPT for Financial Services With Major Industry PartnersOpenAI has introduced a version of ChatGPT built specifically for the financial sector, teaming up with several large brokerages and research organizations, including Morgan Stanley and S&P. The...
September 10, 2026 - 04:58
InMed Reports Full Year Fiscal 2026 Financial Results and Provides Corporate UpdateVancouver-based InMed Pharmaceuticals has released its financial results for the full fiscal year that ended on June 30, 2026, alongside a broader update on its corporate activities. The company,...